Amy Jo Sterling

Array ( [id] => 6567437 [patent_doc_number] => 20020112251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses' [patent_app_type] => new [patent_app_number] => 09/803589 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31481 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20020112251.pdf [firstpage_image] =>[orig_patent_app_number] => 09803589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999912 [patent_doc_number] => 20020028508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive , therapeutic and other uses' [patent_app_type] => new [patent_app_number] => 09/790264 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 51094 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028508.pdf [firstpage_image] =>[orig_patent_app_number] => 09790264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5787105 [patent_doc_number] => 20020160416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Receptor from TNF family' [patent_app_type] => new [patent_app_number] => 09/779050 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17890 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160416.pdf [firstpage_image] =>[orig_patent_app_number] => 09779050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651150 [patent_doc_number] => 20030105021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'TNF-derived peptides for use in treating oedema' [patent_app_type] => new [patent_app_number] => 09/779703 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6205 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105021.pdf [firstpage_image] =>[orig_patent_app_number] => 09779703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612664 [patent_doc_number] => 07148061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function' [patent_app_type] => utility [patent_app_number] => 10/203495 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 27 [patent_no_of_words] => 18698 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/148/07148061.pdf [firstpage_image] =>[orig_patent_app_number] => 10203495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829162 [patent_doc_number] => 20020068696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Trade molecules and uses related thereto' [patent_app_type] => new [patent_app_number] => 09/780532 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 52433 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068696.pdf [firstpage_image] =>[orig_patent_app_number] => 09780532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313410 [patent_doc_number] => 06607726 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Human tumor necrosis factor receptor TR10' [patent_app_type] => B1 [patent_app_number] => 09/769402 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25413 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/607/06607726.pdf [firstpage_image] =>[orig_patent_app_number] => 09769402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1274434 [patent_doc_number] => 06649589 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Use of certain drugs for treating nerve root injury' [patent_app_type] => B1 [patent_app_number] => 09/743852 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7600 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649589.pdf [firstpage_image] =>[orig_patent_app_number] => 09743852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870054 [patent_doc_number] => 20030082743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Polypeptide sequences of human EDG-1c' [patent_app_type] => new [patent_app_number] => 09/759514 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12957 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082743.pdf [firstpage_image] =>[orig_patent_app_number] => 09759514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560208 [patent_doc_number] => 20020164684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Human tumor necrosis factor receptor TR9' [patent_app_type] => new [patent_app_number] => 09/756854 [patent_app_country] => US [patent_app_date] => 2001-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 35149 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164684.pdf [firstpage_image] =>[orig_patent_app_number] => 09756854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711074 [patent_doc_number] => 20030170823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Novel cytokine ZCYTO18' [patent_app_type] => new [patent_app_number] => 09/746375 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 46264 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170823.pdf [firstpage_image] =>[orig_patent_app_number] => 09746375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 467572 [patent_doc_number] => 07235531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Tachykinin-like polypeptides and use thereof' [patent_app_type] => utility [patent_app_number] => 10/168789 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36507 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235531.pdf [firstpage_image] =>[orig_patent_app_number] => 10168789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593656 [patent_doc_number] => 20020042095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Secreted protein, ZSIG89' [patent_app_type] => new [patent_app_number] => 09/741711 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042095.pdf [firstpage_image] =>[orig_patent_app_number] => 09741711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986811 [patent_doc_number] => 20010036643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Educational kit and method using tumor necrosis factor-stimulated gene and protein' [patent_app_type] => new [patent_app_number] => 09/728912 [patent_app_country] => US [patent_app_date] => 2000-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32102 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036643.pdf [firstpage_image] =>[orig_patent_app_number] => 09728912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1295482 [patent_doc_number] => 06627200 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'Utilization of CD 137 in order to promote the proliferation of peripheral monocytes' [patent_app_type] => B1 [patent_app_number] => 09/623545 [patent_app_country] => US [patent_app_date] => 2000-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10855 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627200.pdf [firstpage_image] =>[orig_patent_app_number] => 09623545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024734 [patent_doc_number] => 06884777 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-26 [patent_title] => 'Method for treating respiratory distress syndrome' [patent_app_type] => utility [patent_app_number] => 09/711295 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6266 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884777.pdf [firstpage_image] =>[orig_patent_app_number] => 09711295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073597 [patent_doc_number] => 06838262 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-04 [patent_title] => 'Isolated DNA molecule encoding rank ligand' [patent_app_type] => utility [patent_app_number] => 09/688459 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16045 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838262.pdf [firstpage_image] =>[orig_patent_app_number] => 09688459 [rel_patent_id] =>[rel_patent_doc_number] =>)